Search Results
Slidesets
Evaluation of Pan Genotypic HCV NS3/4A Protease Inhibitor GS-9857 as the Object of Transporter and Cytochrome P450-Mediated Drug-Drug Interactions - Dr. Brian Kirby
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Slidesets
Prevention and care strategies for the high risk population in Puerto Rico- Carlos Rodriguez-Diaz, PhD
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Slidesets
Use of Integrase Inhibitors in special populations | Omar Sued, MSc, MD, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
WHO Target 90-90-90 : Achievable for Latin America- Alejandro Afani, MD
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Abstracts
Monitoring and management of treatment failure among people on antiretroviral therapy in Mozambique: lessons learned to improve treatment effectiveness
L. Torres
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Slidesets
Characterization of Hepatitis B Virus (HBV) Among Liver Patients in Kenya- Missiani Ochwoto
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018